SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Alivus Life Sciences informs about disclosure

21 Mar 2026 Evaluate
Pursuant to regulation 30(2) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (LODR Regulations) read with clause 20 of Para A of Part A of Schedule III of the LODR Regulations, Alivus Life Sciences has informed that the details of Intimation/Order received by the Company from Income Tax Department is enclosed as Annexure A.

The above information is a part of company’s filings submitted to BSE.

Alivus Life Sciences Share Price

1074.70 0.00 (0.00%)
06-May-2026 10:42 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1831.80
Dr. Reddys Lab 1292.00
Cipla 1347.70
Zydus Lifesciences 925.90
Lupin 2400.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×